<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Esophago-gastroduodenal anastomosis with rats mimics the development of human <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> by introducing mixed reflux of gastric and duodenal contents into the esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>However, use of this rat model for mechanistic and chemopreventive studies is limited due to lack of genetically modified rat strains </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, a mouse model of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is needed </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We performed reflux surgery on <z:mp ids='MP_0002169'>wild-type</z:mp>, p53A135V transgenic, and INK4a/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e>+/- mice of A/J strain </plain></SENT>
<SENT sid="4" pm="."><plain>Some mice were also treated with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> (1,400 ppm in diet), iron (50 mg/kg/m, i.p.), or gastrectomy plus iron </plain></SENT>
<SENT sid="5" pm="."><plain>Mouse esophagi were harvested at 20, 40 or 80 weeks after surgery for histopathological analysis </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: At week 20, we observed <z:mpath ids='MPATH_160'>metaplasia</z:mpath> in <z:mp ids='MP_0002169'>wild-type</z:mp> mice (5%, 1/20) and p53A135V mice (5.3%, 1/19) </plain></SENT>
<SENT sid="7" pm="."><plain>At week 40, <z:mpath ids='MPATH_160'>metaplasia</z:mpath> was found in <z:mp ids='MP_0002169'>wild-type</z:mp> mice (16.2%, 6/37), p53A135V mice (4.8%, 2/42), and <z:mp ids='MP_0002169'>wild-type</z:mp> mice also receiving gastrectomy and iron (6.7%, 1/15) </plain></SENT>
<SENT sid="8" pm="."><plain>Esophageal <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> developed in INK4a/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e>+/- mice (7.1%, 1/14), and <z:mp ids='MP_0002169'>wild-type</z:mp> mice receiving gastrectomy and iron (21.4%, 3/14) </plain></SENT>
<SENT sid="9" pm="."><plain>Among 13 <z:mp ids='MP_0002169'>wild-type</z:mp> mice which were given iron from week 40 to 80, twelve (92.3%) developed <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> at week 80 </plain></SENT>
<SENT sid="10" pm="."><plain>None of these mice developed esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Surgically induced <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> produced esophageal <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo>, but not esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, in mice </plain></SENT>
<SENT sid="12" pm="."><plain>Dominant negative p53 mutation, heterozygous loss of INK4a/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e>, antacid treatment, iron supplementation, or gastrectomy failed to promote esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in these mice </plain></SENT>
<SENT sid="13" pm="."><plain>Further studies are needed in order to develop a mouse model of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>